Clover Health Investments, Corp.

Equities

CLOV

US18914F1030

Managed Healthcare

Real-time Estimate Cboe BZX 01:59:09 2024-03-28 pm EDT 5-day change 1st Jan Change
0.791 USD -0.25% Intraday chart for Clover Health Investments, Corp. -8.50% -16.96%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Clover Health Launches New Clinical Program in Partnership with quarter Health to Address Serious Mental Illness CI
Clover Health Investments, Corp.(NasdaqGS:CLOV) dropped from S&P Health Care Services Select Industry Index CI
Transcript : Clover Health Investments, Corp., Q4 2023 Earnings Call, Mar 12, 2024
Earnings Flash (CLOV) CLOVER HEALTH INVESTMENTS Reports Q4 Revenue $510.3M, vs. Street Est of $474M MT
Clover Health Investments, Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Clover Health Investments, Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Clover Health Investments, Corp. Reports Impairment of Goodwill and Other Intangible Assets for the Fourth Quarter Ended December 31, 2023 CI
Clover Health Investments, Corp. Provides Revenue Guidance for the Full Year 2024 CI
Clay Thornton Joins Clover Health as CFO of Medicare Advantage Division CI
North American Morning Briefing : Stock Futures -2- DJ
Transcript : Clover Health Investments, Corp. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 09:00 AM
Clover Health Investments Names Terrence Ronan as Interim Chief Financial Officer MT
Clover Health Investments, Corp. Announces Management Changes CI
Clover Health Investments, Corp. Appoints Terrence Ronan as Interim Chief Financial Officer, Effective January 27, 2024 CI
Clover Health Investments, Corp. Announces Resignation of Scott J. Leffler as Chief Financial Officer, Effective January 26, 2024 CI
Transcript : Clover Health Investments, Corp., Q3 2023 Earnings Call, Nov 06, 2023
Earnings Flash (CLOV) CLOVER HEALTH INVESTMENTS Posts Q3 Revenue $482.1M, vs. Street Est of $494.6M MT
Clover Health Investments, Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Clover Health Investments, Corp. Updates Earnings Guidance for the Full Year 2023 CI
Clover Health Promotes Karen Soares to General Counsel CI
Clover Health Investments, Corp.(NasdaqGS:CLOV) added to S&P Health Care Services Select Industry Index CI
Citigroup Adjusts Price Target on Clover Health Investments to $1.50 From $1, Maintains Neutral Rating MT
Transcript : Clover Health Investments, Corp., Q2 2023 Earnings Call, Aug 08, 2023
Earnings Flash (CLOV) CLOVER HEALTH INVESTMENTS Reports Q2 Revenue $513.6M, vs. Street Est of $490.8M MT
Clover Health Investments, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Chart Clover Health Investments, Corp.
More charts
Clover Health Investments, Corp. is a physician enablement company. The Company is focused on seniors who have historically lacked access to affordable healthcare. It offers a software platform, Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making and improve health outcomes. The Company operates under two segments: Insurance and Non-Insurance. Through its Insurance segment, it provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. The Company's Non-Insurance segment consists of operations in connection with its participation in the Direct Contracting program. The Company’s subsidiaries include Clover Health Labs, LLC, Medical Service Professionals of NJ LLC, Clover HMO of New Jersey Inc., Clover Health Holdings, Inc. and Clover Health Partners, LLC.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.793 USD
Average target price
1.333 USD
Spread / Average Target
+68.14%
Consensus
  1. Stock
  2. Equities
  3. Stock Clover Health Investments, Corp. - Nasdaq
  4. News Clover Health Investments, Corp.
  5. Clover Health Investments : BofA Securities Downgrades Clover Health Investments to Neutral Rating From Buy on Disappointing Q1 Results, Lowers PT to $9 From $15